The American laboratory Gilead announced Wednesday that its drug remdesivir had shown "positive" results in patients of Covid-19 in the framework of a large clinical trial eagerly awaited, carried out in partnership with the American Institutes of Health.
>> LIVE - Coronavirus: follow the evolution of the situation Wednesday April 29
"Gilead Sciences is aware of positive data from a study by the National Institute of Allergy and Infectious Diseases on its antiviral drug remdesivir for the treatment of Covid-19," the company said, without providing further details.
CORONAVIRUS ESSENTIALS
> How many deaths at home should be added to the epidemic?
> What is the purpose of AlloCOVID, the telephone platform that uses artificial intelligence?
> Why we will have to wait before finding masks in pharmacies
> Coronavirus: can the MMR vaccine be dangerous for children?
> These platforms which help to find a job during confinement